Saranac Partners Ltd Increases Holdings in AMETEK, Inc. $AME

Saranac Partners Ltd boosted its stake in AMETEK, Inc. (NYSE:AME) by 56.1% in the 4th quarter, Holdings Channel reports. The firm owned 40,183 shares of the technology company’s stock after buying an additional 14,447 shares during the quarter. AMETEK accounts for approximately 3.2% of Saranac Partners Ltd’s portfolio, making the stock its 11th biggest position. Saranac Partners Ltd’s holdings in AMETEK were worth $8,273,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the stock. Vanguard Group Inc. boosted its holdings in AMETEK by 0.7% in the 3rd quarter. Vanguard Group Inc. now owns 27,173,705 shares of the technology company’s stock worth $5,108,657,000 after acquiring an additional 176,040 shares during the period. State Street Corp boosted its stake in shares of AMETEK by 1.3% in the third quarter. State Street Corp now owns 9,763,684 shares of the technology company’s stock valued at $1,835,573,000 after purchasing an additional 126,381 shares during the period. Invesco Ltd. grew its holdings in AMETEK by 4.9% during the 3rd quarter. Invesco Ltd. now owns 4,463,518 shares of the technology company’s stock valued at $839,141,000 after purchasing an additional 209,043 shares in the last quarter. Flossbach Von Storch SE increased its stake in AMETEK by 1.0% during the 4th quarter. Flossbach Von Storch SE now owns 3,820,376 shares of the technology company’s stock worth $784,361,000 after buying an additional 36,535 shares during the period. Finally, Lazard Asset Management LLC lifted its holdings in AMETEK by 35.7% in the 3rd quarter. Lazard Asset Management LLC now owns 2,645,977 shares of the technology company’s stock worth $497,444,000 after buying an additional 695,419 shares in the last quarter. 87.43% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. Oppenheimer downgraded AMETEK from an “outperform” rating to a “market perform” rating in a research note on Tuesday, January 27th. Morgan Stanley boosted their price target on AMETEK from $215.00 to $235.00 and gave the stock an “equal weight” rating in a research note on Thursday, March 12th. BMO Capital Markets started coverage on AMETEK in a research note on Friday, March 27th. They set an “outperform” rating and a $253.00 price objective for the company. Truist Financial reaffirmed a “buy” rating and issued a $275.00 target price (up from $265.00) on shares of AMETEK in a research report on Monday, May 4th. Finally, Deutsche Bank Aktiengesellschaft began coverage on AMETEK in a research report on Wednesday, January 21st. They issued a “buy” rating and a $271.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $252.33.

Insider Activity

In related news, Director Thomas A. Amato sold 530 shares of the company’s stock in a transaction that occurred on Tuesday, March 24th. The stock was sold at an average price of $216.78, for a total transaction of $114,893.40. Following the sale, the director directly owned 4,480 shares of the company’s stock, valued at approximately $971,174.40. This represents a 10.58% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.54% of the company’s stock.

AMETEK Stock Performance

Shares of AMETEK stock opened at $221.10 on Wednesday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 0.72 and a current ratio of 1.14. AMETEK, Inc. has a 1 year low of $174.43 and a 1 year high of $243.18. The firm’s 50-day simple moving average is $225.04 and its 200-day simple moving average is $216.70. The firm has a market cap of $50.68 billion, a PE ratio of 33.40, a price-to-earnings-growth ratio of 3.17 and a beta of 1.03.

AMETEK (NYSE:AME) last posted its quarterly earnings results on Thursday, April 30th. The technology company reported $1.97 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.07. The business had revenue of $1.93 billion during the quarter, compared to the consensus estimate of $1.91 billion. AMETEK had a return on equity of 16.63% and a net margin of 20.11%.The company’s revenue for the quarter was up 11.3% compared to the same quarter last year. During the same period last year, the firm earned $1.75 earnings per share. AMETEK has set its FY 2026 guidance at 7.940-8.140 EPS and its Q2 2026 guidance at 1.960-2.000 EPS. Equities analysts forecast that AMETEK, Inc. will post 8.13 earnings per share for the current fiscal year.

AMETEK Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, June 15th will be issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Monday, June 15th. AMETEK’s payout ratio is 20.54%.

AMETEK Profile

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.